Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects.

Alpha- and beta-myosin heavy chain (MHC), the two MHC isoforms expressed in the mammalian heart, differ quantitatively in their enzymatic activities. The MHC composition of the heart can change dramatically in response to numerous stimuli, leading to the hypothesis that changes in cardiac function can be caused by myosin isoform shifts. However, this hypothesis has remained unproven because the stimuli used to generate these shifts are complex and accompanied by many additional physiological changes, including alterations in cardiac mass and geometry. Adult mouse ventricles normally express only alpha-MHC (the faster motor). To determine whether genetic alteration of the MHC isoform composition in the adult mouse heart would result in changes in cardiac chamber mass and contractility, we established transgenic mouse lines that express a Myc-tagged beta-MHC molecule (the slower motor) in adult ventricular tissue, one of which expresses 12% of its myosin as the transgene. There is no evidence of hypertrophy, induction of hypertrophic markers, and no histopathology. Myofibrillar Ca(2+)-activated ATPase activity is decreased by 23%, and Langendorff preparations demonstrate a significant 15% decrease in systolic function in transgenic hearts. These results suggest that even small shifts in the myosin isoform composition of the myocardium can result in physiologically significant changes in cardiac contractility and could be relevant to cardiovascular disease.

[1]  L. Leinwand,et al.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. , 1998, Biophysical journal.

[2]  B. Hainque,et al.  Familial hypertrophic cardiomyopathy: from mutations to functional defects. , 1998, Circulation research.

[3]  J. Towbin,et al.  The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.

[4]  M. Bond,et al.  Troponin I phosphorylation and myofilament calcium sensitivity during decompensated cardiac hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.

[5]  L. Leinwand,et al.  Myosin heavy chain gene expression in human heart failure. , 1997, The Journal of clinical investigation.

[6]  B. Groves,et al.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. , 1997, The Journal of clinical investigation.

[7]  T. Hewett,et al.  Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. , 1997, Circulation research.

[8]  M. Ikebe,et al.  Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome. , 1996, The Journal of clinical investigation.

[9]  T. Hewett,et al.  Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. , 1996, The Journal of clinical investigation.

[10]  G. Fishman,et al.  Conditional transgene expression in the heart. , 1996, Circulation research.

[11]  N. Alpert,et al.  Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. , 1995, Circulation research.

[12]  H. Yamashita,et al.  Dynamic interaction between cardiac myosin isoforms modifies velocity of actomyosin sliding in vitro. , 1993, Circulation research.

[13]  I. Grupp,et al.  Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. , 1991, Circulation research.

[14]  B. Nadal-Ginard,et al.  Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. , 1989, The Journal of clinical investigation.

[15]  T. Gustafson,et al.  Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. , 1987, The Journal of biological chemistry.

[16]  G K Lewis,et al.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.

[17]  N. Alpert,et al.  The Economy of Isometric Force Development, Myosin Isoenzyme Pattern and Myofibrillar ATPase Activity in Normal and Hypothyroid Rat Myocardium , 1985, Circulation research.

[18]  J. Hoh,et al.  The ATPase activities of rat cardiac myosin isoenzymes , 1980, FEBS letters.

[19]  R. Solaro,et al.  The purification of cardiac myofibrils with Triton X-100. , 1971, Biochimica et biophysica acta.

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  L. Leinwand,et al.  The mammalian myosin heavy chain gene family. , 1996, Annual review of cell and developmental biology.

[22]  M. Ashburner.  A Laboratory manual , 1989 .

[23]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[24]  I. Grupp,et al.  Isolated Heart Preparations Perfused or Superfused with Balanced Salt Solutions , 1984 .